Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03773302
Brief Title: Phase 3 Study of BGJ398 (Oral Infigratinib) in First Line Cholangiocarcinoma With FGFR2 Gene Fusions/Translocations

First Submitted : December 10, 2018
First Submitted that Met QC Criteria : December 10, 2018
First Posted : December 12, 2018

Last Update Submitted that Met QC Criteria : January 25, 2021
Last Update Posted : January 27, 2021